Senti Biosciences (NASDAQ:SNTI) reported quarterly losses of $(0.38) per share.
Cowen & Co. Downgrades Quanterix to Market Perform, Lowers Price Target to $18
Cowen & Co. analyst Max Masucci downgrades Quanterix (NASDAQ:QTRX) from Outperform to Market Perform and lowers the price target from $38 to $18.